| Literature DB >> 33149280 |
Kyunghee Noh1,2, Duc-Hiep Bach1, Hyun-Jin Choi1,3, Mark S Kim1, Sherry Y Wu1, Sunila Pradeep1, Cristina Ivan4,5, Min-Soon Cho6, Emine Bayraktar1, Cristian Rodriguez-Aguayo4,5, Santosh K Dasari1, Elaine Stur1, Lingegowda S Mangala1,4, Gabriel Lopez-Berestein4,5, Anil K Sood7,8,9.
Abstract
Paxillin (PXN), a key component of the focal adhesion complex, has been associated with cancer progression, but the underlying mechanisms are poorly understood. The purpose of this study was to elucidate mechanisms by which PXN affects cancer growth and progression, which we addressed using cancer patient data, cell lines, and orthotopic mouse models. We demonstrated a previously unrecognized mechanism whereby nuclear PXN enhances angiogenesis by transcriptionally regulating SRC expression. SRC, in turn, increases PLAT expression through NF-ĸB activation; PLAT promotes angiogenesis via LRP1 in endothelial cells. PXN silencing in ovarian cancer mouse models reduced angiogenesis, tumor growth, and metastasis. These findings provide a new understanding of the role of PXN in regulating tumor angiogenesis and growth.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33149280 PMCID: PMC8275353 DOI: 10.1038/s41388-020-01517-3
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867